Beta-Thalassemia Clinical Trials in Shanghai, Shanghai Municipality
3 recruitingShanghai, Shanghai Municipality, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Beta-ThalassemiaMyelodysplastic Syndromes (MDS)Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
Celgene665 enrolled143 locationsNCT04064060
Recruiting
Not Applicable
A Long-term Follow-up Study in Participants Who Received CS-101
Beta-Thalassemia
Children's Hospital of Fudan University5 enrolled1 locationNCT06479616
Recruiting
Phase 1Phase 2
Β-Thalassemia Treatment with KL003 Cell Injection
Transfusion Dependent Beta-Thalassemia
Kanglin Biotechnology (Hangzhou) Co., Ltd.41 enrolled2 locationsNCT06280378